MagPlex C Microsphere Beads
ID: 75D30124Q78391Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/f82828d5ec4949d8aa83c43f743678d1/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking quotations for the supply of MagPlex C Microsphere Beads, which are critical for serological assays used to quantify antibodies for various disease targets in public health surveillance. These microspheres are uniquely compatible with the CDC's existing assays based on Luminex’s Xmap technology, and no alternative products have been identified that can replace them without compromising the integrity of past study comparisons. Interested vendors must submit their quotations by 5:00 PM EST on September 10, 2024, with delivery expected by December 31, 2024; inquiries should be directed to Gary Morgan at glm5@cdc.gov or by phone at 770-488-2639.

    Point(s) of Contact
    Gary Morgan
    (770) 488-2639
    (770) 488-2777
    glm5@cdc.gov
    Files
    Title
    Posted
    75D30124Q78391 MagPlex C Microsphere Beads.doc
    The document is a Request for Quotations (RFQ) issued by the Centers for Disease Control and Prevention (CDC), seeking quotes for MagPlex-C microsphere beads for various regions. The RFQ, numbered 75D301-24-Q-78391, communicates a solicitation to vendors, indicating that it is not an order but a request for information. It specifies that bids should be submitted via email by September 5, 2024, and stresses that deliveries must occur by December 31, 2024. The RFQ outlines the quantities required for different regions, totaling 22 individual items of 4ml microsphere beads each. The document incorporates various Federal Acquisition Regulation (FAR) clauses, detailing obligations related to payment, contractor performance evaluation, and compliance with accessibility standards. It encourages small business participation but does not initially set aside an allocation for them. The RFQ's structure adheres to common federal procurement procedures, providing detailed instructions for contractors regarding compliance, performance assessment, and payment processes.
    75D30124Q78391 MagPlex C Microsphere Beads extend RFQ Sept 9.doc
    The document is a Request for Quotations (RFQ) issued by the Centers for Disease Control and Prevention (CDC) on August 28, 2024. It seeks quotes for the supply of MagPlex-C Microsphere Beads in various regional quantities. The RFQ emphasizes that it is not an order, nor does it commit the government to payment for any preparation costs. Interested parties must submit their quotations by September 10, 2024, and provide delivery by December 31, 2024. The document outlines the necessary details, including the point of contact, Gary Morgan, along with guidelines for quote submissions, payment terms, and clauses incorporated by reference regarding contractor performance and compliance with federal regulations. Additionally, it highlights the importance of adhering to supply chain security standards and accessibility requirements under Section 508 of the Rehabilitation Act. The RFQ is aimed at ensuring compliance with contracting rules and is designed to facilitate the procurement process for necessary supplies to support CDC operations effectively.
    Lifecycle
    Title
    Type
    MagPlex C Microsphere Beads
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Oligo CVV Production
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified contractors to provide rapid custom genetic products for the development of Candidate Vaccine Viruses (CVVs) against pandemic potential. The procurement includes single-stranded DNA oligonucleotides and double-stranded DNA gene fragments, with specific requirements for turnaround times, expected yields, and shipping arrangements to ensure timely delivery of these critical genetic materials. This initiative is vital for enhancing the nation's preparedness for future pandemics, emphasizing the need for flexibility in production to adapt to rapidly changing influenza strains. Interested vendors must submit their quotes by September 16, 2024, and can contact Timothy Joyce at xvf7@cdc.gov for further information.
    ThermoFisher branded Invitrogen ProcartaPlex immunoassay kits (Brand Name restriction)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for ThermoFisher branded Invitrogen ProcartaPlex immunoassay kits as part of a combined synopsis/solicitation. The procurement aims to acquire specific immunoassay kits necessary for testing human cytokine and chemokine levels in serum and saliva samples from individuals with alcohol use disorder, which is critical for ongoing research into the effects of alcohol consumption on health. The required kits must be capable of detecting and quantifying a panel of 80 targets simultaneously and are essential for ensuring continuity and comparability across various studies conducted by the NIH Clinical Center. Interested vendors must submit their offers by September 17, 2024, to Lu Chang at lu-chang.lu@nih.gov, including pricing and delivery timelines, as late submissions will not be considered.
    Notice of Intent to Sole Source Axisoscope Microscope
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source contract for the procurement of a Zeiss Axioscope 5 microscope system, which includes advanced fluorescence and darkfield imaging capabilities. This specialized equipment is critical for ongoing research related to HIV and sexually transmitted infections, as it offers superior imaging capabilities essential for high-quality live cell imaging and quantitative analysis, surpassing alternative products. Interested parties may submit capability statements or proposals for consideration, with all responses due by the specified deadline; inquiries can be directed to Jillian Martinez at uhs0@cdc.gov or Stephanie Reid at qsi5@cdc.gov.
    Notice of Intent to Sole Source to Micromeritics Instrument Corp for the Procurement of a High Performance Gas Pycnometer
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to enter into a sole source contract with Micromeritics Instrument Corp for the procurement of a High Performance Gas Pycnometer, specifically the AccuPyc III 1350 model. This laboratory instrument is required to measure the true density of powders and dusts with a precision of 0.02% accuracy and 0.01% repeatability, operating within a temperature range of 5 to 60°C. The high-performance capabilities of this pycnometer are crucial for ensuring accurate measurement data, which is essential for experiments involving particle density and sedimentation. Interested parties may submit quotations or responses to Lena Torres at dgb1@cdc.gov by 4:30 p.m. EST on September 16, 2024, although this notice is not a request for competitive quotations.
    CDC Small Business Engagement Summit
    Active
    Health And Human Services, Department Of
    Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF intends to award a sole source contract to QIAGEN, LLC for the procurement of an EZ! Advanced XL System. This system is typically used for In-Vitro Diagnostic Substance Manufacturing. The contract is for supplies or services under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested parties may submit proposals within five days of the issuance of this notice. The deadline for submission is 06:00AM, July 24, 2023.
    Qiagen Real Time Semi-Quantitative PCR (RT-qPCR) and Digital PCR (dPCR) System or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a Qiagen Real Time Semi-Quantitative PCR (RT-qPCR) and Digital PCR (dPCR) System or an equivalent product. The procurement aims to support research into neurodegenerative diseases and retroviral infections, requiring a system with multiplex capability for detecting five gene targets, automated operation, low variability in results, and a compact size not exceeding 16” x 28” x 20”. Proposals must be submitted by 9:00 a.m. Eastern Time on September 17, 2024, and should include a completed copy of certain FAR clauses and the Unique Entity ID. For further inquiries, interested parties can contact Frederick Weddington at frederick.weddington@nih.gov or by phone at 301-594-6835.
    Surface Plasmon Resonance (SPR) Instrument- Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for a Surface Plasmon Resonance (SPR) Instrument, either brand name or equal, to support its Vaccine Research Center's structural biology efforts. The procurement aims to acquire a high-throughput SPR instrument that meets specific technical requirements, including dimensions, weight, temperature ranges, and data collection capabilities, to facilitate biophysical and structural analysis of macromolecules. This equipment is critical for advancing research in infectious diseases and vaccine development. Interested vendors must submit their quotes by 4:30 PM EST on September 19, 2024, to Hershea Vance at hershea.vance@nih.gov, and ensure compliance with all specified requirements and clauses outlined in the solicitation documents.
    Multi-Antigen Diagnostic Tests
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services (HHS) is seeking proposals for the procurement of one million FDA-approved multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B, under solicitation number 75A50424R00006. This initiative is a 100% Small Business Set-Aside, aimed at replenishing the diagnostics stockpile in response to public health demands, with all tests required to originate from the original equipment manufacturer (OEM) and meet specific FDA standards. The selected contractor will deliver the kits to designated government warehouses, with delivery commencing 15 days post-award and a total performance period of 12 months. Proposals must be submitted electronically by 4:00 PM ET on September 17, 2024, to IBMSCC-Submissions@hhs.gov, with inquiries directed to Christopher Newell at christopher.newell@hhs.gov.
    Automated Liquid Handling Systems– Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two automated liquid handling systems, either brand name or equal, to support the Vaccine Production Program (VPP) at the National Institute of Allergy and Infectious Diseases (NIAID). These systems are critical for high-throughput, microscale protein purification and product characterization, which are essential for developing vaccines against various pathogens, including HIV and SARS-COV-2. Interested vendors must submit their quotes by 12:00 PM EST on September 23, 2024, to Daveta H. Brown at daveta.brown@nih.gov, ensuring compliance with all specified requirements and regulations outlined in the solicitation documents.
    Mass Spectrometer
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotations for a Brand Name or Equal Bruker Daltonics Mass Spectrometer Model timsTOF flex to replace a decommissioned unit within its Vaccine Production Program (VPP). This procurement is critical for maintaining and enhancing mass spectrometry capabilities that support vaccine development against infectious diseases such as HIV, Ebola, and Zika, particularly in light of recent global health challenges. The selected vendor must deliver the equipment within 30 days of contract award, and quotes are due by September 19, 2024. Interested vendors should direct inquiries to Uju Obii-Obioha at uju.obii-obioha@nih.gov or Linda Smith at linda.smith2@nih.gov for further information.